AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 63 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 6.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $53,899 | -46.8% | 32,469 | -46.5% | 0.00% | 0.0% |
| Q2 2021 | $101,331 | -62.0% | 60,677 | +70.9% | 0.00% | -50.0% |
| Q1 2015 | $267,000 | -31.2% | 35,504 | -23.5% | 0.00% | -33.3% |
| Q2 2014 | $388,000 | +147.1% | 46,428 | +87.8% | 0.00% | +200.0% |
| Q1 2014 | $157,000 | -10.8% | 24,723 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $176,000 | -4.9% | 24,723 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $185,000 | +29.4% | 24,723 | -0.4% | 0.00% | 0.0% |
| Q2 2013 | $143,000 | – | 24,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |